Impulsive Behavior: Clinical Trials

5 trials for Impulsive Behavior, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 recruiting. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Recruiting 5
Phase 21Recruiting 1

Follow Impulsive Behavior: new trials by email Literature Review of Impulsive Behavior trials Research Report on Impulsive Behavior

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Evaluation of Nicotine Analogs
Biospecimen Collection, Nicotine, 6-Methyl Nicotine - Tobacco-Related Carcinoma, Addiction
Phase 1RecruitingOhio State University Comprehensive Cancer Center702026-05-292026-06-26
Nalmefene Implant in Healthy Subjects
1 Nalmefene implant, 2 Nalmefene implants - Opioid Abuse and Addiction
Phase 1RecruitingReacX Pharmaceuticals, Inc.242026-02-232026-04-06
Ketamine for Combined Depression and Alcohol Use Disorder
Ketamine Hydrochloride, Midazolam Hydrochloride - Depression, Alcohol Use Disorder
Phase 1 / Phase 2RecruitingUniversity Hospital of North Norway342025-01-202026-06-23
Open-Label Psilocybin Study in Transdiagnostic Population
Psilocybin - Transdiagnostic, Depression - Major Depressive Disorder
Phase 1RecruitingYale University502024-10-172026-10-30
Frontal iTBS for Impulsivity and Suicidal Ideation in Veterans With Mild Traumatic Brain Injury
intermittent theta burst stimulation, placebo intermittent theta burst stimulation - Mild Traumatic Brain Injury, Suicidal Ideation
Phase 1RecruitingVA Office of Research and Development552024-05-202026-04-14

Narrower conditions

Behavior, Addictive (4)  ·  Depression (2)  ·  Alcoholism (1)  ·  Anxiety Disorders (1)  ·  Brain Concussion (1)  ·  Brain Diseases (1)  ·  Brain Injuries (1)  ·  Brain Injuries, Traumatic (1)  ·  Craniocerebral Trauma (1)  ·  Mental Disorders (1)  ·  Opioid-Related Disorders (1)  ·  Risk-Taking (1)  ·  Self-Injurious Behavior (1)  ·  Stress Disorders, Post-Traumatic (1)

Broader conditions

Behavior (5)  ·  Compulsive Behavior (4)  ·  Behavioral Symptoms (3)  ·  Chemically-Induced Disorders (3)  ·  Mental Disorders (3)  ·  Substance-Related Disorders (2)  ·  Alcohol-Related Disorders (1)  ·  Central Nervous System Diseases (1)  ·  Head Injuries, Closed (1)  ·  Narcotic-Related Disorders (1)  ·  Nervous System Diseases (1)  ·  Stress Disorders, Traumatic (1)  ·  Trauma and Stressor Related Disorders (1)  ·  Trauma, Nervous System (1)

Interventions

Ketamine (1)  ·  Midazolam (1)  ·  Niacinamide (1)  ·  Nicotine (1)  ·  Psilocybin (1)  ·  Specimen Handling (1)

Sponsors

Ohio State University Comprehensive Cancer Center (1)  ·  ReacX Pharmaceuticals, Inc. (1)  ·  University Hospital of North Norway (1)  ·  VA Office of Research and Development (1)  ·  Yale University (1)

Countries

United States (4)  ·  Norway (1)

Top investigators

Alexandra L Aaronson, MD (1)  ·  Andreas W Blomkvist, M.D. (1)  ·  Benjamin Kelmendi, MD (1)  ·  Gabrielle Agin-Liebes, PhD (1)  ·  Theodore L Wagener, PhD (1)

Results publications

PMID 39671573

NIH funding

2023 (1)